Rapacan 2mg Tablet (Sirolimus 2mg)

Rapacan 2mg Tablet

Rapacan 2Mg Capsule is an immuno-suppressant, which in combination with other medications is used during kidney transplant to prevent rejection. It is also used to coat coronary stents and treat lymphangioleiomyomatosis. This medicine is is usually taken once daily, but consult your doctor regarding the right dosage. It is available as a chewing tablet as well as in liquid form.

Do not use this medicine or consult a doctor first in case; you have a history of allergic reactions to medicines or are allergic to any of the ingredients; you have had a liver or lung problems; you are taking any other prescription medicines, especially mifepristone, posaconazole, rifabutin, enzalutamide, erythromycin, or voriconazole; if you are pregnant, planning to become pregnant or are breastfeeding; have high cholesterol or blood sugar, or low blood platelet count.

Some side effects of this medicine include shaking, acne, trouble sleeping, Diarrhea, joint pain, abdominal pain, headache, constipation, bruising, nasal congestion, blurred vision, burning while urinating, fever, earache, dry mouth, sore throat, fatigue. Seek immediate medical attention in case the effects are serious or if you notice any other symptoms such as itching, rash, hives, difficulty breathing, swollen, red, cracked, scaly skin or swelling of the face, throat, tongue, lips or eyes.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Internal Medicine Specialist before using this medicine.

Related Product

Side Effects

Nausea

Headache

Abdominal Pain

Viral Infections

Pneumonia

Reduced Blood Platelets

Increased Heart Rate

Decreased White Blood Cell Count

Anemia

Urinary Tract Infection

Diarrhoea

Increased Blood Pressure

Bacterial Infections

Fungal Infections

Constipation

Herpes Simplex Virus Infections

work

The active constituent of this medication is an immunosuppressive agent that works by binding to the immunophilin FK Binding Protein-12 (FKBP-12) and generating an immunosuppressive compound. It works by diminishing main regulatory kinase, mTOR (mammalian Target Of Rapamycin), causing inhibition of cytokine-driven T-cell proliferation.